SCHEMBL29644792

SCHEMBL29644792

F[C@@H]1CN(Cc2ccccc2)C[C@H]1F

nearest known ligand 0.60

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
FUCA1 P04066 2/20 0.60
SIGMAR1 Q99720 2/20 0.58
S1PR1 P21453 1/20 0.51
S1PR5 Q9H228 1/20 0.51
ACHE P22303 1/20 0.50
GBA1 P04062 1/20 0.50
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C19 P33261 1/20 0.49
ALDH1A1 P00352 1/20 0.49
CCR3 P51677 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1836650 1.00 FUCA1 (0.60) FUCA1SIGMAR1S1PR1S1PR5ACHE
SCHEMBL14986453 0.87 FUCA1 (0.51) FUCA1SIGMAR1S1PR1S1PR5ACHE
SCHEMBL16740670 0.87 FUCA1 (0.51) FUCA1SIGMAR1S1PR1S1PR5ACHE
SCHEMBL14986672 0.87 FUCA1 (0.51) FUCA1SIGMAR1S1PR1S1PR5ACHE
SCHEMBL16714621 0.87 FUCA1 (0.51) FUCA1SIGMAR1S1PR1S1PR5ACHE
SCHEMBL30014513 0.87 FUCA1 (0.71) FUCA1SIGMAR1S1PR1S1PR5GBA1
SCHEMBL4503331 0.84 GBA1 (0.49) FUCA1SIGMAR1S1PR1S1PR5ACHE
SCHEMBL4506217 0.84 GBA1 (0.49) FUCA1SIGMAR1S1PR1S1PR5ACHE
SCHEMBL500415 0.84 GBA1 (0.49) FUCA1SIGMAR1S1PR1S1PR5ACHE
SCHEMBL4503332 0.84 GBA1 (0.49) FUCA1SIGMAR1S1PR1S1PR5ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114507215-B Compound serving as PAK4 kinase inhibitor and preparation method and application thereof 成都海博为药业有限公司 2024-09-13 CN disclosed
CN-114507215-A Compound serving as PAK4 kinase inhibitor and preparation method and application thereof 成都海博为药业有限公司 2022-05-17 CN disclosed